Viscosupplementation Market Set to Achieve Remarkable Growth with a Projected CAGR of 7.5% by 2030
According to a new report published by MarkWide Research, titled, “Viscosupplementation Market,” the global viscosupplementation market is poised for substantial growth, with a projected Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period from 2023 to 2030. Viscosupplementation, a minimally invasive medical procedure that involves injecting gel-like substances into joints to alleviate pain and enhance joint mobility, is gaining traction as a viable solution for managing osteoarthritis-related discomfort.
The prevalence of osteoarthritis, particularly among the aging population, has contributed to an increased demand for effective and long-lasting pain relief solutions. Viscosupplementation offers a non-surgical approach that has shown promising results in providing relief to patients suffering from joint pain and limited mobility.
One of the key factors driving the growth of the viscosupplementation market is the rising geriatric population across the globe. As individuals age, the likelihood of experiencing osteoarthritis and associated joint problems increases, thereby fueling the demand for therapies that enhance their quality of life. Furthermore, the increasing awareness among patients about minimally invasive treatments, coupled with advancements in medical technology, has paved the way for the widespread adoption of viscosupplementation procedures.
The report highlights the North American region as a significant player in the viscosupplementation market. With well-established healthcare infrastructure and a higher adoption rate of advanced medical treatments, North America is expected to retain its dominance throughout the forecast period. Moreover, the Asia-Pacific region is anticipated to exhibit substantial growth, attributed to the rapid development of healthcare facilities, increasing healthcare expenditure, and a growing geriatric population.
The research report also delves into the competitive landscape of the viscosupplementation market. Key players operating in this market are focusing on strategic initiatives such as product innovations, mergers and acquisitions, and partnerships to gain a competitive edge. The report profiles some of the prominent companies in the market, providing a comprehensive understanding of their business strategies and product offerings.
In terms of product types, the single-injection segment holds a significant share of the market. The convenience and effectiveness of single-injection viscosupplements have contributed to their widespread adoption. However, the report suggests that the three-injection segment is anticipated to witness substantial growth, owing to its long-lasting pain-relief benefits.
Dr. Samantha Carter, a senior healthcare analyst at MarkWide Research, stated, “The viscosupplementation market is poised for remarkable growth in the coming years. The increasing prevalence of osteoarthritis and the growing preference for non-surgical treatment options are driving the demand for viscosupplementation procedures. Market players are investing in research and development to develop innovative and advanced products, which will further augment market growth.”
The “Viscosupplementation Market” report provides a comprehensive analysis of market trends, growth drivers, challenges, and opportunities. It presents a detailed segmentation of the market based on product type, end-user, and region. The report offers insightful data and forecasts that will assist businesses and stakeholders in making informed decisions and devising effective strategies to tap into the lucrative opportunities in the viscosupplementation market.
In conclusion, the global viscosupplementation market is on a trajectory of robust growth, driven by the increasing prevalence of osteoarthritis and the growing adoption of minimally invasive treatment options. With a projected CAGR of 7.5% from 2023 to 2030, the market presents attractive opportunities for both established players and new entrants seeking to make their mark in the healthcare industry.